Revolutionizing Kidney Transplantation: A Breakthrough Investment
On September 22, 2025, the National Kidney Foundation (NKF) announced a significant advancement in the field of kidney transplantation. Through its Innovation Fund, NKF is investing in BMI OrganBank, a pioneering medical device company based in Winston-Salem, North Carolina. This funding is a crucial step in preparing for the upcoming clinical study of BMI OrganBank’s groundbreaking room temperature machine perfusion (RTMP) platform. This innovative technology aims to enhance kidney transplant outcomes and decrease the wait times for patients seeking life-saving transplants.
BMI OrganBank’s Next-Gen Technology
BMI OrganBank’s RTMP technology is at the forefront of organ preservation and assessment technologies. Recently receiving FDA Breakthrough Device Designation, this portable kidney preservation device is designed to transform the organ transplant landscape significantly. The RTMP platform not only allows for the functional assessment of kidneys prior to transplant but also extends their preservation times. This is particularly vital given that over 90,000 Americans are currently waiting for kidney transplants, highlighting the urgent need for viable organ options.
The Importance of Every Donated Kidney
Kevin Longino, the CEO of the National Kidney Foundation and a kidney transplant recipient himself, emphasized the importance of this investment: “Every kidney that goes unused represents a life that could have been saved.” Longino’s statement encapsulates the mission of NKF to reduce the number of discarded kidneys, thereby increasing the availability of life-saving transplants for those in dire need.
A Collaborative Effort for Progress
Carrie DiMarzio, CEO of BMI OrganBank, expressed gratitude for the strategic investment from NKF, stating, “We are honored to receive this investment, which significantly advances our efforts to validate RTMP technology through clinical studies.” This collaboration between NKF and BMI OrganBank marks a pivotal moment in the journey to enhance kidney health solutions, demonstrating how partnerships can expedite medical advancements.
The Role of the NKF Innovation Fund
The NKF Innovation Fund plays a vital role in fostering innovation in kidney health. Designed to accelerate solutions for improving kidney health, the fund invests in early-stage companies that focus on developing promising therapies and technologies. By bridging the gap between discovery and application, NKF helps innovators deliver effective solutions to patients, addressing a critical need in kidney care.
Understanding Kidney Disease
Kidney disease, or chronic kidney disease (CKD), is a significant health concern in the United States, affecting an estimated 37 million adults. Alarmingly, around 90% of those affected are unaware of their condition. One in three adults is at risk, with various factors like diabetes, high blood pressure, and obesity contributing to the development of kidney-related issues. Additionally, certain demographics, especially individuals of Black or African American descent, face a higher likelihood of kidney failure, being over four times more affected than their White counterparts.
BMI OrganBank’s Vision
BMI OrganBank specializes in transformative perfusion systems for organ and tissue evaluation and preservation. Their flagship portable kidney device, co-developed with leading transplant surgeons, is on the verge of entering clinical studies, indicating a promising future for kidney transplantation technologies. With facilities located at the Innovation Quarter in Winston-Salem and Research Triangle Park in North Carolina, BMI OrganBank is poised to make significant contributions to organ preservation advancements.
The Mission of the National Kidney Foundation
The National Kidney Foundation is dedicated to eliminating preventable kidney disease and accelerating innovation in kidney care. Through initiatives aimed at improving patient experience and addressing structural inequities, NKF is committed to transforming the landscape of kidney health. For anyone seeking more information about kidney health and available resources, the NKF offers a wealth of knowledge.
In summary, the strategic investment by the National Kidney Foundation in BMI OrganBank heralds a new chapter in kidney transplantation technology. By embracing innovation and fostering collaboration, both organizations are working diligently to improve kidney health outcomes and reduce the burden of kidney disease on individuals and families across the United States.